RecruitingNCT07013344

Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease

Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease: Insights From a Real-World Cohort


Sponsor

IRCCS Ospedale San Raffaele

Enrollment

800 participants

Start Date

Sep 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

This study aim to investigate the association between plasma NT-proBNP levels and the presence, extent and severity of stenosis in patients with suspected coronary artery disease.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying BNP for people with chronic coronary syndrome, chronic coronary total occlusion, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBNP

Measurement of plasma NT-proBNP level.


Locations(2)

IRCCS San Raffaele Hospital

Milan, Italy, Italy

IRCCS San Raffaele Hospital

Milan, Italy, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07013344


Related Trials